Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
92.58
+0.83 (0.90%)
At close: Dec 12, 2025, 4:00 PM EST
92.97
+0.39 (0.42%)
After-hours: Dec 12, 2025, 7:56 PM EST
Boston Scientific Stock Forecast
Stock Price Forecast
The 18 analysts that cover Boston Scientific stock have a consensus rating of "Strong Buy" and an average price target of $125.33, which forecasts a 35.37% increase in the stock price over the next year. The lowest target is $110 and the highest is $140.
Price Target: $125.33 (+35.37%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 9 | 9 | 8 |
| Buy | 11 | 11 | 12 | 12 | 10 | 10 |
| Hold | 2 | 2 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 23 | 22 | 21 | 19 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $132 | Strong Buy | Reiterates | $132 | +42.58% | Nov 21, 2025 |
| UBS | UBS | Strong Buy Maintains $135 → $140 | Strong Buy | Maintains | $135 → $140 | +51.22% | Oct 23, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $129 → $130 | Strong Buy | Maintains | $129 → $130 | +40.42% | Oct 23, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $124 → $125 | Buy | Maintains | $124 → $125 | +35.02% | Oct 23, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $125 → $130 | Buy | Maintains | $125 → $130 | +40.42% | Oct 23, 2025 |
Financial Forecast
Revenue This Year
20.27B
from 16.75B
Increased by 21.05%
Revenue Next Year
22.59B
from 20.27B
Increased by 11.43%
EPS This Year
3.07
from 1.25
Increased by 145.23%
EPS Next Year
3.50
from 3.07
Increased by 14.14%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21.2B | 25.1B | ||||
| Avg | 20.3B | 22.6B | ||||
| Low | 19.6B | 21.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 26.4% | 23.6% | ||||
| Avg | 21.0% | 11.4% | ||||
| Low | 17.2% | 6.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.20 | 3.80 | ||||
| Avg | 3.07 | 3.50 | ||||
| Low | 2.92 | 3.28 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 156.2% | 24.0% | ||||
| Avg | 145.2% | 14.1% | ||||
| Low | 133.6% | 7.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.